📋 Tender Overview
Funded Value6434348Funded PeriodOct 19 - Mar 28FunderEPSRCProject StatusActiveProject CategoryTraining GrantProject ReferenceEPS0230541A drug is a molecule that acts upon biological processes in the body. In contrast a medicine is a complex product that comprises the drug and other ingredients packaged into a final dosage form that can be administered to a patient to ensure there is a beneficial therapeutic effect with minimum side-effects. To achieve therapeutic effect it is essential to ensure that the drug is delivered to the appropriate site in the body at the right time and in the correct amount. This is challenging some drug molecules are poorly soluble in biological milieu while others are either not stable or have toxic side-effects and require careful processing into medicines to ensure they remain biologically active and safe. The new drug molecules arising from drug discovery and biotechnology have particularly challenging properties. Pharmaceutical technologies are central to developing medicines from these molecules to ensure patients are provided with safe and efficacious therapy. The design and development of new medicines is an inherently complex and cross-disciplinary process and requires both innovative research and highly skilled imaginative researchers. To sustain and reinforce the UKs future global competitiveness a new generation of highly-trained graduates educated at doctoral level is required to deliver transformative new therapeutics. Our CDT will train an empowered network of at least 60 PhD students through a consortium of multiple industry partners led by the University of Nottingham and University College London. The involvement of partners from start-ups to major international pharmaceutical companies will ensure that our students receive the cross-disciplinary scientific knowledge needed to develop future medicines and build the leadership resilience and entrepreneurial skills crucial to allow them to function effectively as future leaders and agents of change. Through partnering with industry we will ensure that the research work undertaken in the CDT is of direct relevance to contemporary and future challenges in medicines development. This will allow the CDT research to make significant contributions to the development of new therapies leading ultimately to transformative medicines to treat patients. Beyond the research undertaken in the CDT our graduates will build careers across the pharmaceutical and healthcare sector and will in the future impact society through developing new medicines to improve the health and well-being of individuals across the world. We will train our students in four key science themes i predictive pharmaceutical sciences ii advanced product design iii pharmaceutical process engineering and iv complex product characterisation. This will ensure our graduates are educated to approach challenges in preparing medicines from
